Spyre Therapeutics
SYRE
SYRE
77 hedge funds and large institutions have $322M invested in Spyre Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.04% less ownership
Funds ownership: 3.35% → 3.31% (-0.04%)
1% less funds holding
Funds holding: 78 → 77 (-1)
Holders
77
Holding in Top 10
3
Calls
$90K
Puts
–
Top Buyers
| 1 | +$4.82M | |
| 2 | +$3.58M | |
| 3 | +$1.17M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$506K |
| 5 |
Renaissance Technologies
New York
|
+$394K |
Top Sellers
| 1 | -$3.83M | |
| 2 | -$3.27M | |
| 3 | -$2.67M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.27M |
| 5 |
BlackRock
New York
|
-$954K |